e 4031 has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pillozzi, S | 1 |
| Masselli, M | 1 |
| De Lorenzo, E | 1 |
| Accordi, B | 1 |
| Cilia, E | 1 |
| Crociani, O | 1 |
| Amedei, A | 1 |
| Veltroni, M | 1 |
| D'Amico, M | 1 |
| Basso, G | 1 |
| Becchetti, A | 1 |
| Campana, D | 1 |
| Arcangeli, A | 1 |
1 other study available for e 4031 and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Membrane; Cells, Cultured; Coculture Techniq | 2011 |